4+7-话题@MedSci

#4+7#

94篇内容 | 2693人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1398799, encodeId=f4eb1398e9960, content=<a href='/topic/show?id=794413168f' target=_blank style='color:#2F92EE;'>#4+7#</a>, objectTitle=重磅！4+7未中选药品降价清单公布, objectType=article, longId=161154, objectId=d9a31611549c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d9a31611549c, replyNumber=0, likeNumber=83, createdTime=2019-02-27, rootId=0, userName=ms1260584454294838, userId=1df22500220, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d9a31611549c, moduleTitle=重磅！4+7未中选药品降价清单公布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d9a31611549c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1398798, encodeId=2a9d1398e98a4, content=<a href='/topic/show?id=794413168f' target=_blank style='color:#2F92EE;'>#4+7#</a>, objectTitle=4+7后，还需要药代吗？官方有答复了, objectType=article, longId=160595, objectId=fa88160595e9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fa88160595e9, replyNumber=0, likeNumber=64, createdTime=2019-02-22, rootId=0, userName=ms1260584454294838, userId=1df22500220, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fa88160595e9, moduleTitle=4+7后，还需要药代吗？官方有答复了, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fa88160595e9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1398797, encodeId=06b81398e9778, content=<a href='/topic/show?id=794413168f' target=_blank style='color:#2F92EE;'>#4+7#</a>, objectTitle=“4+7”带量采购再出新政中标“高价药”支付比例将这样定, objectType=article, longId=160552, objectId=d18216055268, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d18216055268, replyNumber=0, likeNumber=56, createdTime=2019-02-21, rootId=0, userName=ms1260584454294838, userId=1df22500220, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d18216055268, moduleTitle=“4+7”带量采购再出新政中标“高价药”支付比例将这样定, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d18216055268)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1398796, encodeId=4c5e1398e96a3, content=<a href='/topic/show?id=794413168f' target=_blank style='color:#2F92EE;'>#4+7#</a>, objectTitle=“4+7”带量采购配套政策落地未中选品种不受“一品两规”限制, objectType=article, longId=160549, objectId=071d1605495d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=071d1605495d, replyNumber=0, likeNumber=59, createdTime=2019-02-21, rootId=0, userName=ms1260584454294838, userId=1df22500220, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=071d1605495d, moduleTitle=“4+7”带量采购配套政策落地未中选品种不受“一品两规”限制, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=071d1605495d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1398795, encodeId=2ef51398e95a7, content=<a href='/topic/show?id=794413168f' target=_blank style='color:#2F92EE;'>#4+7#</a>, objectTitle=“4+7”背景下医疗机构要如何应对？, objectType=article, longId=160525, objectId=22db1605253b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=22db1605253b, replyNumber=0, likeNumber=61, createdTime=2019-02-21, rootId=0, userName=ms1260584454294838, userId=1df22500220, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=22db1605253b, moduleTitle=“4+7”背景下医疗机构要如何应对？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=22db1605253b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1398794, encodeId=f8f71398e94ad, content=<a href='/topic/show?id=794413168f' target=_blank style='color:#2F92EE;'>#4+7#</a>, objectTitle=“4+7”再出新政！未中标“高价药”支付比例这么定, objectType=article, longId=160510, objectId=282b160510fb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=282b160510fb, replyNumber=0, likeNumber=71, createdTime=2019-02-21, rootId=0, userName=ms1260584454294838, userId=1df22500220, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=282b160510fb, moduleTitle=“4+7”再出新政！未中标“高价药”支付比例这么定, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=282b160510fb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1398793, encodeId=25891398e9376, content=<a href='/topic/show?id=794413168f' target=_blank style='color:#2F92EE;'>#4+7#</a>, objectTitle=4+7未中选高价药，提高自负比例, objectType=article, longId=160504, objectId=c8101605041d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c8101605041d, replyNumber=0, likeNumber=69, createdTime=2019-02-21, rootId=0, userName=ms1260584454294838, userId=1df22500220, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c8101605041d, moduleTitle=4+7未中选高价药，提高自负比例, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c8101605041d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1398792, encodeId=97251398e921b, content=<a href='/topic/show?id=794413168f' target=_blank style='color:#2F92EE;'>#4+7#</a>, objectTitle=4+7新政：医保局抓紧“钱袋子”，药品大减价来了！, objectType=article, longId=160361, objectId=0da51603614e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0da51603614e, replyNumber=0, likeNumber=64, createdTime=2019-02-20, rootId=0, userName=ms1260584454294838, userId=1df22500220, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0da51603614e, moduleTitle=4+7新政：医保局抓紧“钱袋子”，药品大减价来了！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0da51603614e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1398791, encodeId=a4061398e9114, content=<a href='/topic/show?id=794413168f' target=_blank style='color:#2F92EE;'>#4+7#</a>, objectTitle=北京4+7配套措施公布, objectType=article, longId=160327, objectId=a37116032e1e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a37116032e1e, replyNumber=0, likeNumber=62, createdTime=2019-02-19, rootId=0, userName=ms1260584454294838, userId=1df22500220, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a37116032e1e, moduleTitle=北京4+7配套措施公布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a37116032e1e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1398790, encodeId=c56e1398e90bb, content=<a href='/topic/show?id=794413168f' target=_blank style='color:#2F92EE;'>#4+7#</a>, objectTitle=18过一致性评价药，比4+7贵几十倍, objectType=article, longId=160267, objectId=c14016026e1c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c14016026e1c, replyNumber=0, likeNumber=144, createdTime=2019-02-19, rootId=0, userName=ms1260584454294838, userId=1df22500220, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c14016026e1c, moduleTitle=18过一致性评价药，比4+7贵几十倍, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c14016026e1c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1398789, encodeId=9c9b1398e8928, content=<a href='/topic/show?id=794413168f' target=_blank style='color:#2F92EE;'>#4+7#</a>, objectTitle=干货！4+7政策落地全汇总, objectType=article, longId=160266, objectId=dd3316026661, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dd3316026661, replyNumber=0, likeNumber=60, createdTime=2019-02-19, rootId=0, userName=ms1260584454294838, userId=1df22500220, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dd3316026661, moduleTitle=干货！4+7政策落地全汇总, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dd3316026661)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1398788, encodeId=cc211398e88b8, content=<a href='/topic/show?id=794413168f' target=_blank style='color:#2F92EE;'>#4+7#</a>, objectTitle=医改明星省份大动作！全省推进4+7带量采购, objectType=article, longId=160263, objectId=3c1916026348, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3c1916026348, replyNumber=0, likeNumber=60, createdTime=2019-02-19, rootId=0, userName=ms1260584454294838, userId=1df22500220, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3c1916026348, moduleTitle=医改明星省份大动作！全省推进4+7带量采购, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3c1916026348)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1398787, encodeId=0f221398e87d8, content=<a href='/topic/show?id=794413168f' target=_blank style='color:#2F92EE;'>#4+7#</a>, objectTitle=4+7带量采购，开始联动了？！, objectType=article, longId=160179, objectId=103c1601e996, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=103c1601e996, replyNumber=0, likeNumber=74, createdTime=2019-02-18, rootId=0, userName=ms1260584454294838, userId=1df22500220, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=103c1601e996, moduleTitle=4+7带量采购，开始联动了？！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=103c1601e996)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1398786, encodeId=1c441398e86df, content=<a href='/topic/show?id=794413168f' target=_blank style='color:#2F92EE;'>#4+7#</a>, objectTitle=北京4+7配套措施流出！, objectType=article, longId=160176, objectId=6f681601e6ab, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6f681601e6ab, replyNumber=0, likeNumber=47, createdTime=2019-02-18, rootId=0, userName=ms1260584454294838, userId=1df22500220, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6f681601e6ab, moduleTitle=北京4+7配套措施流出！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6f681601e6ab)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1398785, encodeId=d74c1398e8518, content=<a href='/topic/show?id=794413168f' target=_blank style='color:#2F92EE;'>#4+7#</a>, objectTitle=国家卫健委：4+7中标品种不受药占比、一品两规限制, objectType=article, longId=159170, objectId=ac5a1591e0d6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ac5a1591e0d6, replyNumber=0, likeNumber=61, createdTime=2019-01-31, rootId=0, userName=ms1260584454294838, userId=1df22500220, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ac5a1591e0d6, moduleTitle=国家卫健委：4+7中标品种不受药占比、一品两规限制, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ac5a1591e0d6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1398784, encodeId=65111398e8455, content=<a href='/topic/show?id=794413168f' target=_blank style='color:#2F92EE;'>#4+7#</a>, objectTitle=4+7带量采购，合同来了, objectType=article, longId=158634, objectId=cf2b1586348a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cf2b1586348a, replyNumber=0, likeNumber=116, createdTime=2019-01-24, rootId=0, userName=ms1260584454294838, userId=1df22500220, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cf2b1586348a, moduleTitle=4+7带量采购，合同来了, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cf2b1586348a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1398783, encodeId=e4b91398e83c7, content=<a href='/topic/show?id=794413168f' target=_blank style='color:#2F92EE;'>#4+7#</a>, objectTitle=又一城市4+7方案公布, objectType=article, longId=158497, objectId=718d15849eb3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=718d15849eb3, replyNumber=0, likeNumber=49, createdTime=2019-01-22, rootId=0, userName=ms1260584454294838, userId=1df22500220, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=718d15849eb3, moduleTitle=又一城市4+7方案公布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=718d15849eb3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1398782, encodeId=b2fd1398e82c1, content=<a href='/topic/show?id=794413168f' target=_blank style='color:#2F92EE;'>#4+7#</a>, objectTitle=“4+7”正式落地详解国务院发布的带量采购方案政策, objectType=article, longId=158454, objectId=8b5715845405, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8b5715845405, replyNumber=0, likeNumber=67, createdTime=2019-01-21, rootId=0, userName=ms1260584454294838, userId=1df22500220, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8b5715845405, moduleTitle=“4+7”正式落地详解国务院发布的带量采购方案政策, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8b5715845405)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1398781, encodeId=1f851398e81d5, content=<a href='/topic/show?id=794413168f' target=_blank style='color:#2F92EE;'>#4+7#</a>, objectTitle=4+7上海新动作：未中标品种，降价？！, objectType=article, longId=158449, objectId=226b15844901, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=226b15844901, replyNumber=0, likeNumber=75, createdTime=2019-01-21, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=226b15844901, moduleTitle=4+7上海新动作：未中标品种，降价？！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=226b15844901)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1398780, encodeId=43af1398e80f1, content=<a href='/topic/show?id=794413168f' target=_blank style='color:#2F92EE;'>#4+7#</a>, objectTitle=4+7后，这些药企的机会到了, objectType=article, longId=158270, objectId=87891582e050, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=87891582e050, replyNumber=0, likeNumber=84, createdTime=2019-01-19, rootId=0, userName=ms1260584454294838, userId=1df22500220, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=87891582e050, moduleTitle=4+7后，这些药企的机会到了, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=87891582e050)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

4+7

2020-05-29

ms1260584454294838 (审核中...)

前往app查看评论内容

#4+7#

重磅！4+7未中选药品降价清单公布

2019-02-27

ms1260584454294838 (审核中...)

前往app查看评论内容

#4+7#

4+7后，还需要药代吗？官方有答复了

2019-02-22

ms1260584454294838 (审核中...)

前往app查看评论内容

#4+7#

“4+7”带量采购再出新政中标“高价药”支付比例将这样定

2019-02-21

ms1260584454294838 (审核中...)

前往app查看评论内容

#4+7#

“4+7”带量采购配套政策落地未中选品种不受“一品两规”限制

2019-02-21

ms1260584454294838 (审核中...)

前往app查看评论内容

#4+7#

“4+7”背景下医疗机构要如何应对？

2019-02-21

ms1260584454294838 (审核中...)

前往app查看评论内容

#4+7#

“4+7”再出新政！未中标“高价药”支付比例这么定

2019-02-21

ms1260584454294838 (审核中...)

前往app查看评论内容

#4+7#

4+7未中选高价药，提高自负比例

2019-02-21

ms1260584454294838 (审核中...)

前往app查看评论内容

#4+7#

4+7新政：医保局抓紧“钱袋子”，药品大减价来了！

2019-02-20

ms1260584454294838 (审核中...)

前往app查看评论内容

#4+7#

北京4+7配套措施公布

2019-02-19

ms1260584454294838 (审核中...)

前往app查看评论内容

#4+7#

18过一致性评价药，比4+7贵几十倍

2019-02-19

ms1260584454294838 (审核中...)

前往app查看评论内容

#4+7#

干货！4+7政策落地全汇总

2019-02-19

ms1260584454294838 (审核中...)

前往app查看评论内容

#4+7#

医改明星省份大动作！全省推进4+7带量采购

2019-02-19

ms1260584454294838 (审核中...)

前往app查看评论内容

#4+7#

4+7带量采购，开始联动了？！

2019-02-18

ms1260584454294838 (审核中...)

前往app查看评论内容

#4+7#

北京4+7配套措施流出！

2019-02-18

ms1260584454294838 (审核中...)

前往app查看评论内容

#4+7#

国家卫健委：4+7中标品种不受药占比、一品两规限制

2019-01-31

ms1260584454294838 (审核中...)

前往app查看评论内容

#4+7#

4+7带量采购，合同来了

2019-01-24

ms1260584454294838 (审核中...)

前往app查看评论内容

#4+7#

又一城市4+7方案公布

2019-01-22

ms1260584454294838 (审核中...)

前往app查看评论内容

#4+7#

“4+7”正式落地详解国务院发布的带量采购方案政策

2019-01-21

仁者大医 (审核中...)

前往app查看评论内容

#4+7#

4+7上海新动作：未中标品种，降价？！

2019-01-21

ms1260584454294838 (审核中...)

前往app查看评论内容

#4+7#

4+7后，这些药企的机会到了

2019-01-19

科室
- - 订阅+
  - 更多科室
工具
服务